CB, the big three, probably nowhere to be found at this point, especially FedEx.. I gather that's why Shelton has not included those partners in his forecast.. If just one of the big 3 delivers something this fiscal year, it would be Icing on the cake..
The one excerpt from yesterday's press release which is probably something we longs should be focusing on, I posted and I believe Laser posted as well, the following. " CryoPort was actively supporting the logistics needs for 34 clinical trials including six phase III programs." If one of the phase 3 trials gets early approval, and we know NeoStem has that opportunity, commercialization COULD BE worth millions in revenue..
The other area that I continue to watch closely as well, Car T Cell companies. Kite, Bluebird and Juno.. CryoPort is such an Integral part to their process. And Car T Cell is currently the hottest sector in the biotech arena.. A little pin action would be nice..
News 
Market Data 
Discover 
